arrow
L

Laurence W. Busse

Emory University
H指数:36
被引数:7,222

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influenza vaccine effectiveness against influenza A-associated hospitalization and severe in-hospital outcomes among adults in the United States, 2024–2025

2024–2025年度美国成人人群中流感疫苗对流感A相关住院及院内严重结局的保护效果

2026-09-260
PRE
Genomic surveillance of human metapneumovirus in the United States, 2010–2025

2010–2025年美国人类偏肺病毒的基因组监测

2026-05-060
PRE
Clinical criteria for the definition of refractory septic shock: a joint Delphi consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)

难治性败血症休克定义的临床标准: 重症监护医学会 (SCCM) 和欧洲重症监护医学会 (ESICM) 联合Delphi共识

2026-03-240
PRE
Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial

多粘菌素B血液灌流吸附治疗内毒素性脓毒性休克(Tigris):一项多中心、开放标签、贝叶斯、随机对照、III期试验

2026-03-230
OAAI
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus

成人呼吸道合胞病毒感染的多重共病模式与院内严重预后

2025-08-010
PRE
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination

与呼吸道合胞病毒疫苗接种相关的患者层面和社区层面特征

2025-04-010
OA
An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock

血管扩张性休克中血管紧张素II治疗初始血压反应的指标及其与临床结局的关联

2025-02-190
OA
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19

二肽基peptidase-3和肾素 (SPiDeR) 在新型冠状病毒肺炎低氧血症患者中的休克预测

2025-02-010
PRE
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United 2019-2022

2019-2022年美国住院成人中COVID-19和流感疫苗犹豫现象

VACCINE
IF3.5
2025-02-010
PRE
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study

早期奥司他韦治疗对甲型流感住院成人患者的益处: 一项观察性研究

2024-11-281
OA
Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023

2022年9月-2023年8月,原始单价和二价新型冠状病毒肺炎疫苗对美国成人COVID-19-Associated住院和严重住院结局的有效性

2024-11-040
OA